本文源自：智通财经网 智通财经获悉，据港交所11月28日披露，龙丰集团控股有限公司(简称：龙丰集团)递表港交所主板，星 展银行为独家保荐人。招股书显示，龙丰集团是一家以香港为基地、以"龙丰"品牌营运的领先连锁零售 药妆百货营运商。根据弗若斯特沙利文报告，2024年，按零售销售额计，公司是香港最大的药品零售 商，市场份额为5.2%；且按平均单店可供应的SKU计，是香港最大的药妆零售商，平均单店可供应约 6,500个SKU。 截至最后实际可行日期，公司致力透过于香港设有的29间零售店铺及各类线上销售平台，为顾客提供种 类繁多而物超所值的产品。公司位于旺角家乐坊的旗舰店总楼面面积约17,500平方呎，根据弗若斯特沙 利文的资料，以总楼面面积计，为2024年香港最大的药妆零售店。 ...

Group 1 - The core point of the article is that Longfeng Group Holdings Limited has submitted an application to list on the Hong Kong Stock Exchange, with DBS Bank as the sole sponsor [1] - Longfeng Group is a leading chain retailer of drugstore and cosmetics in Hong Kong, operating under the "Longfeng" brand [1] - According to a report by Frost & Sullivan, Longfeng Group is projected to be the largest pharmaceutical retailer in Hong Kong by retail sales in 2024, holding a market share of 5.2% [1] - The company is also the largest cosmetics retailer in Hong Kong based on the average number of SKUs available per store, with approximately 6,500 SKUs per store [1] - As of the latest practical date, Longfeng Group operates 29 retail stores in Hong Kong and various online sales platforms to provide a wide range of value-for-money products [1] - The flagship store located in Mong Kok's Carrefours has a total floor area of approximately 17,500 square feet, making it the largest drugstore retail store in Hong Kong by total floor area in 2024 according to Frost & Sullivan [1]